272 related articles for article (PubMed ID: 26149659)
1. Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10/10, 9/10-HLA matched donors and cord blood.
Granier C; Biard L; Masson E; Porcher R; Peffault de Latour R; Robin M; Boissel N; Xhaard A; Ribaud P; Lengline E; Larghero J; Charron D; Loiseau P; Socié G; Dhédin N
Am J Hematol; 2015 Oct; 90(10):897-903. PubMed ID: 26149659
[TBL] [Abstract][Full Text] [Related]
2. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
[TBL] [Abstract][Full Text] [Related]
3. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658
[TBL] [Abstract][Full Text] [Related]
4. Single Antigen-Mismatched Unrelated Hematopoietic Stem Cell Transplantation Using High-Dose Post-Transplantation Cyclophosphamide Is a Suitable Alternative for Patients Lacking HLA-Matched Donors.
Jorge AS; Suárez-Lledó M; Pereira A; Gutierrez G; Fernández-Avilés F; Rosiñol L; Llobet N; Solano T; Urbano-Ispízua Á; Rovira M; Martínez C
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1196-1202. PubMed ID: 29410343
[TBL] [Abstract][Full Text] [Related]
5. Effect of graft source on unrelated donor hemopoietic stem cell transplantation in adults with acute myeloid leukemia after reduced-intensity or nonmyeloablative conditioning: a study from the Société Francaise de Greffe de Moelle et de Thérapie Cellulaire.
Malard F; Milpied N; Blaise D; Chevallier P; Michallet M; Lioure B; Clément L; Hicheri Y; Cordonnier C; Huynh A; Yakoub-Agha I; Peffault de Latour R; Mohty M
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1059-67. PubMed ID: 25708220
[TBL] [Abstract][Full Text] [Related]
6. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
[TBL] [Abstract][Full Text] [Related]
7. Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.
Bachanova V; Burns LJ; Wang T; Carreras J; Gale RP; Wiernik PH; Ballen KK; Wirk B; Munker R; Rizzieri DA; Chen YB; Gibson J; Akpek G; Costa LJ; Kamble RT; Aljurf MD; Hsu JW; Cairo MS; Schouten HC; Bacher U; Savani BN; Wingard JR; Lazarus HM; Laport GG; Montoto S; Maloney DG; Smith SM; Brunstein C; Saber W
Bone Marrow Transplant; 2015 Feb; 50(2):197-203. PubMed ID: 25402415
[TBL] [Abstract][Full Text] [Related]
8. Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party.
Robin M; Ruggeri A; Labopin M; Niederwieser D; Tabrizi R; Sanz G; Bourhis JH; van Biezen A; Koenecke C; Blaise D; Tischer J; Craddock C; Maillard N; Mohty M; Russel N; Schetelig J; Finke J; Gluckman E; de Witte TM; Rocha V; Kroger N
Biol Blood Marrow Transplant; 2015 Mar; 21(3):489-95. PubMed ID: 25529382
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic cell transplantation in pediatric patients with acute leukemias or myelodysplastic syndrome using unrelated adult or umbilical cord blood donors in Brazil.
Tavares RCB; Bonfim CS; Seber A; Pereira Lermontov S; Coulturato V; Zecchin VG; Ribeiro L; Fernandes JF; Daudt LE; Grecco CS; Darrigo-Jr LG; Villela N; Nichele S; Gouveia R; Bouzas LF; Hamerschlak N; Vigorito AC; da Silva PM; da Silva PO; da Silva CC; de Souza Fernandez C; Flowers ME; Arcuri LJ
Pediatr Transplant; 2020 Nov; 24(7):e13789. PubMed ID: 32757316
[TBL] [Abstract][Full Text] [Related]
10. A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia.
Piemontese S; Ciceri F; Labopin M; Arcese W; Kyrcz-Krzemien S; Santarone S; Huang H; Beelen D; Gorin NC; Craddock C; Gulbas Z; Bacigalupo A; Mohty M; Nagler A;
J Hematol Oncol; 2017 Jan; 10(1):24. PubMed ID: 28103944
[TBL] [Abstract][Full Text] [Related]
11. A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
Devillier R; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Harbi S; Granata A; D'Incan E; Coso D; Chabannon C; Picard C; Etienne A; Calmels B; Schiano JM; Lemarie C; Stoppa AM; Bouabdallah R; Vey N; Blaise D
Am J Hematol; 2014 Jan; 89(1):83-7. PubMed ID: 24108528
[TBL] [Abstract][Full Text] [Related]
12. Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.
Ballen K; Woo Ahn K; Chen M; Abdel-Azim H; Ahmed I; Aljurf M; Antin J; Bhatt AS; Boeckh M; Chen G; Dandoy C; George B; Laughlin MJ; Lazarus HM; MacMillan ML; Margolis DA; Marks DI; Norkin M; Rosenthal J; Saad A; Savani B; Schouten HC; Storek J; Szabolcs P; Ustun C; Verneris MR; Waller EK; Weisdorf DJ; Williams KM; Wingard JR; Wirk B; Wolfs T; Young JH; Auletta J; Komanduri KV; Lindemans C; Riches ML
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1636-1645. PubMed ID: 27343716
[TBL] [Abstract][Full Text] [Related]
13. Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation.
Baron F; Labopin M; Ruggeri A; Mohty M; Sanz G; Milpied N; Bacigalupo A; Rambaldi A; Bonifazi F; Bosi A; Sierra J; Yakoub-Agha I; Santasusana JM; Gluckman E; Nagler A
J Hematol Oncol; 2015 Oct; 8():107. PubMed ID: 26445106
[TBL] [Abstract][Full Text] [Related]
14. HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants.
Elia L; Arcese W; Torello M; Iori AP; Guglielmi C; Perrone MP; Screnci M; Sprovieri T; Rapanotti MC; Cimino G
Haematologica; 1999 Jun; 84(6):530-4. PubMed ID: 10366797
[TBL] [Abstract][Full Text] [Related]
15. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
Rocha V; Labopin M; Sanz G; Arcese W; Schwerdtfeger R; Bosi A; Jacobsen N; Ruutu T; de Lima M; Finke J; Frassoni F; Gluckman E; ;
N Engl J Med; 2004 Nov; 351(22):2276-85. PubMed ID: 15564544
[TBL] [Abstract][Full Text] [Related]
16. Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation.
Gutman JA; Ross K; Smith C; Myint H; Lee CK; Salit R; Milano F; Delaney C; Gao D; Pollyea DA
Bone Marrow Transplant; 2016 Dec; 51(12):1588-1593. PubMed ID: 27400068
[TBL] [Abstract][Full Text] [Related]
17. Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders.
Kwon M; Balsalobre P; Serrano D; Pérez Corral A; Buño I; Anguita J; Gayoso J; Diez-Martin JL
Biol Blood Marrow Transplant; 2013 Jan; 19(1):143-9. PubMed ID: 22960386
[TBL] [Abstract][Full Text] [Related]
18. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
[TBL] [Abstract][Full Text] [Related]
19. Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor.
Ringdén O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J
Bone Marrow Transplant; 2008 Nov; 42(10):643-8. PubMed ID: 18762760
[TBL] [Abstract][Full Text] [Related]
20. CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus.
Mikulska M; Raiola AM; Bruzzi P; Varaldo R; Annunziata S; Lamparelli T; Frassoni F; Tedone E; Galano B; Bacigalupo A; Viscoli C
Biol Blood Marrow Transplant; 2012 Jan; 18(1):92-9. PubMed ID: 21689774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
